US Physical Therapy
USPH
150 hedge funds and large institutions have $572M invested in US Physical Therapy in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 8 closing their positions.
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
7% more funds holding
Funds holding: 140 → 150 (+10)
4% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 52
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4.65% less ownership
Funds ownership: 99.05% → 94.39% (-4.7%)
13% less capital invested
Capital invested by funds: $659M → $572M (-$88M)
Top Buyers
| 1 |
Neuberger Berman Group
New York
|
+$5.67M |
| 2 |
Bank of New York Mellon
New York
|
+$2.16M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$2.12M |
| 4 |
AAM
Aberdeen Asset Management
Aberdeen,
United Kingdom
|
+$2.08M |
| 5 |
WI
WBI Investments
Red Bank,
New Jersey
|
+$2.03M |
Top Sellers
USPH Hedge Fund Activity: Q1 2016 in Review
150 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in US Physical Therapy (USPH) for Q1 2016, worth a combined $572M — down 13% from $659M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new USPH positions and 8 closed out — a net gain of 10 holders — while 54 added to existing stakes and 52 trimmed.
The largest buyer was Neuberger Berman Group, adding an estimated $5.67M. The largest seller was Royce & Associates, cutting an estimated $14.7M.
- 150 institutional investors held US Physical Therapy (USPH) as of Q1 2016, up from 140 in Q4 2015.
- Funds reported $572M of US Physical Therapy stock for Q1 2016, down 13% quarter-over-quarter.
- 18 funds opened new US Physical Therapy positions in Q1 2016 and 8 closed out, a net change of +10 holders.
- The largest US Physical Therapy buyer in Q1 2016 was Neuberger Berman Group, an estimated $5.67M added.
- The largest US Physical Therapy seller in Q1 2016 was Royce & Associates, an estimated $14.7M sold.
Based on aggregated 13F filings for Q1 2016.